Literature DB >> 1864308

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate.

S L Erdö1, M Schäfer.   

Abstract

The capacity of memantine to protect cultured cerebrocortical cells against N-methyl-D-aspartate (NMDA)- and glutamate-induced cell death was examined. Excitotoxic cell death was evaluated by phase contrast microscopy and quantified by estimating the release of lactic dehydrogenase from damaged cells. Memantine showed a strong, long-lasting and concentration-dependent protective effect against the excitotoxic damage induced by glutamate and NMDA, with almost complete protection being attained at a memantine concentration of 0.1 mM. The present findings indicate that memantine has potential value as a drug against excitotoxic brain damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864308     DOI: 10.1016/0014-2999(91)90625-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Strategies for the protection of dopaminergic neurons against neurotoxicity.

Authors:  M Gerlach; K L Double; M B Youdim; P Riederer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

Review 3.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

4.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 5.  Memantine: a review of its use in Alzheimer's disease.

Authors:  Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

Authors:  Shashank M Dravid; Kevin Erreger; Hongjie Yuan; Katherine Nicholson; Phuong Le; Polina Lyuboslavsky; Antoine Almonte; Ernest Murray; Cara Mosely; Jeremy Barber; Adam French; Robert Balster; Thomas F Murray; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

Review 7.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

8.  NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

Authors:  Simon M Manning; Delia M Talos; Chengwen Zhou; Debra B Selip; Hyun-Kyung Park; Chang-Joo Park; Joseph J Volpe; Frances E Jensen
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

Review 9.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Carla M Yuede; Carolyn Coughlan; Brian Lewis; John G Csernansky
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.